Literature DB >> 18692948

Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer.

Maria Alice G Gonçalves1, Magali Le Discorde, Renata T Simões, Michele Rabreau, Edson G Soares, Eduardo A Donadi, Edgardo D Carosella.   

Abstract

OBJECTIVES: Viruses and tumour cells may regulate the expression of HLA molecules on the cell surface to escape immune system surveillance. Absence of classical HLA class I molecules may impair the action of specific cytotoxic cells, whereas non-classical HLA class I molecules may regulate innate and adaptive immune cells. We assess here the possible associations between classical/non-classical class I HLA and p16(INK4a) molecule expression in cervical biopsies of women infected with HPV, stratified according to grade of the lesion and HPV type. STUDY
DESIGN: Cervical biopsies (N=74) presenting cervical intraepithelial neoplasia grade 1 (CIN1) (n=31), CIN2-3 (n=19), and invasive cancer (n=14) were evaluated alongside 10 normal cervical specimens.
RESULTS: HLA-A/B/C/G staining was observed in the early stages of HPV infection. A significant association was detected between HLA-A/B/C staining and HPV16/18 infection (OR=0.12, 95%CI: 0.0163-0.7899; p=0.04). HLA-E expression increased with the progression of the lesion (chi(2)-test for trend=4.01; p=0.05), and a significant association was found between HLA-E staining and HPV16/18 infection (OR=11.25, 95%CI: 2.324-54.465; p=0.003). Irrespective of the grade of the lesion, HLA-A/B/C staining and p16(INK4a) presented a good concordance (Kappa: 0.67).
CONCLUSIONS: HLA-E overexpression seemed to be associated with invasive cancer and HPV16/18 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692948     DOI: 10.1016/j.ejogrb.2008.06.010

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  15 in total

1.  HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.

Authors:  Marloes Gooden; Margit Lampen; Ekaterina S Jordanova; Ninke Leffers; J Baptist Trimbos; Sjoerd H van der Burg; Hans Nijman; Thorbald van Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

Review 2.  HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.

Authors:  Michael Campoli; Soldano Ferrone
Journal:  Semin Immunopathol       Date:  2011-04-28       Impact factor: 9.623

3.  Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.

Authors:  Scott G Hansen; Meaghan H Hancock; Daniel Malouli; Emily E Marshall; Colette M Hughes; Kurt T Randall; David Morrow; Julia C Ford; Roxanne M Gilbride; Andrea N Selseth; Renee Espinosa Trethewy; Lindsey M Bishop; Kelli Oswald; Rebecca Shoemaker; Brian Berkemeier; William J Bosche; Michael Hull; Lorna Silipino; Michael Nekorchuk; Kathleen Busman-Sahay; Jacob D Estes; Michael K Axthelm; Jeremy Smedley; Danica Shao; Paul T Edlefsen; Jeffrey D Lifson; Klaus Früh; Jay A Nelson; Louis J Picker
Journal:  Sci Immunol       Date:  2022-06-17

4.  A critical role of non-classical MHC in tumor immune evasion in the amphibian Xenopus model.

Authors:  Nikesha Haynes-Gilmore; Maureen Banach; Eva-Stina Edholm; Edith Lord; Jacques Robert
Journal:  Carcinogenesis       Date:  2014-04-28       Impact factor: 4.944

5.  Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV).

Authors:  Marcia C M Guimarães; Christiane P Soares; Eduardo A Donadi; Sophie F M Derchain; Liliana A L A Andrade; Tarsia G A Silva; Marcela K Hassumi; Renata T Simões; Fabiana A Miranda; Régia C P Lira; Janaina Crispim; Edson G Soares
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

6.  Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors.

Authors:  Sara Soto-De Leon; Milena Camargo; Ricardo Sanchez; Marina Munoz; Antonio Perez-Prados; Antonio Purroy; Manuel Elkin Patarroyo; Manuel Alfonso Patarroyo
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

7.  Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.

Authors:  Debbie M Ferns; A Marijne Heeren; Sanne Samuels; Maaike C G Bleeker; Tanja D de Gruijl; Gemma G Kenter; Ekaterina S Jordanova
Journal:  J Immunother Cancer       Date:  2016-11-15       Impact factor: 13.751

8.  High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.

Authors:  John P Veluchamy; A Marijne Heeren; Jan Spanholtz; Jaap D H van Eendenburg; Daniëlle A M Heideman; Gemma G Kenter; Henk M Verheul; Hans J van der Vliet; Ekaterina S Jordanova; Tanja D de Gruijl
Journal:  Cancer Immunol Immunother       Date:  2016-10-25       Impact factor: 6.968

9.  HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.

Authors:  Vivian M Spaans; Alexander A W Peters; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  J Transl Med       Date:  2012-09-04       Impact factor: 5.531

Review 10.  Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions.

Authors:  Fabio Morandi; Vito Pistoia
Journal:  Front Immunol       Date:  2014-08-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.